Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 8Tumor-Agnostic 4Genitourinary 3Thoracic 2Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 258Lung Neoplasms 207Adenocarcinoma of Lung 44Small Cell Lung Carcinoma 31Adenocarcinoma, Bronchiolo-Alveolar 23Brain Neoplasms 17Breast Neoplasms 14Neoplasm Metastasis 12Mesothelioma, Malignant 10Radiation Injuries 8Neoplasms 8Prostatic Neoplasms 7Melanoma 7Thymoma 6Squamous Cell Carcinoma of Head and Neck 6NSCLC 6Head and Neck Neoplasms 6Drug-Related Side Effects and Adverse Reactions 6Carcinoma, Renal Cell 6Pancreatic Neoplasms 4Esophageal Neoplasms 4Advanced NSCLC 4Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Kidney Neoplasms 3Esthesioneuroblastoma, Olfactory 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Thyroid Neoplasms 2

Interventions

Carboplatin 12Pemetrexed 11pembrolizumab 10Paclitaxel 6Cisplatin 6Erlotinib Hydrochloride 5Docetaxel 5Nivolumab 4Gefitinib 4spartalizumab 3osimertinib 3Gemcitabine 3EC145 3Crizotinib 3Afatinib 3technetium 99m etarfolatide 2pralsetinib 2fludarabine 2cemiplimab 2brigatinib 2alpha-2'-deoxythioguanosine 2aldesleukin 2Vinorelbine 2Radiotherapy 2Quality of Life 2MORAb-202 2Immunotherapy 2Drug Therapy 2Cyclophosphamide 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma × Radiotherapy × Thoracic × Clear all
NCT00563784 2019-11-20

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

M.D. Anderson Cancer Center

Phase 2 Completed
68 enrolled 11 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Adenocarcinoma, Clear Cell, Carcinoma, Giant Cell

NCT01511081 2017-12-07

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

M.D. Anderson Cancer Center

Phase 2 Terminated
21 enrolled 5 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡